Home
Studies
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
ID
NCT04271475
Status
Active
DZG
DZL
Start date
07/07/2020
Contact
Contacts
Leuchte
Hanno Prof. Dr.
Emails
sekretariat.med2@krankenhaus-neuwittelsbach.de
Parameters
Inclusion criteria
persitstent/recurrent CTEPH
Exclusion criteria
operable CTEPH
View raw data